Single Extracellular VEsicle Nanoscopy
Journal of Extracellular Vesicles · 2023-07 · 12 (7)
DOI: 10.1002/jev2.12346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 08.07.2023. Verfasst von Andras Saftics und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology and Molecular Medicine, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, California, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NICHD NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Extracellular vesicles (EVs) and their cargo constitute novel biomarkers. EV subpopulations have been defined not only by abundant tetraspanins (e.g., CD9, CD63 and CD81) but also by specific markers derived from their source cells. However, it remains a challenge to robustly isolate and characterize EV subpopulations. Here, we combined affinity isolation with super‐resolution imaging to comprehensively assess EV subpopulations from human plasma. Our Single Extracellular VEsicle Nanoscopy (SEVEN) assay successfully quantified the number of affinity‐isolated EVs, their size, shape, molecular tetraspanin content, and heterogeneity. The number of detected tetraspanin‐enriched EVs positively correlated with sample dilution in a 64‐fold range (for SEC‐enriched plasma) and a 50‐fold range (for crude plasma). Importantly, SEVEN robustly detected EVs from as little as ∼0.1 μL of crude plasma. We further characterized the size, shape and molecular tetraspanin content (with corresponding heterogeneities) for CD9‐, CD63‐ and CD81‐enriched EV subpopulations. Finally, we assessed EVs from the plasma of four pancreatic ductal adenocarcinoma patients with resectable disease. Compared to healthy plasma, CD9‐enriched EVs from patients were smaller while IGF1R‐enriched EVs from patients were larger, rounder and contained more tetraspanin molecules, suggestive of a unique pancreatic cancer‐enriched EV subpopulation. This study provides the method validation and demonstrates that SEVEN could be advanced into a platform for characterizing both disease‐associated and organ‐associated EV subpopulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cancer Biology and Molecular Medicine, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
- Cardiology Division and Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Surgery, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
- Neurogenomics Division, Translational Genomics Research Institute, Phoenix, Arizona, USA.
ORCID-Profile: Andras Saftics
Förderung
- NICHD NIH HHS
- NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- National Institutes of Health
Zitieren
APA
Saftics, A., Abuelreich, S., Romano, E., Ghaeli, I., Jiang, N., Spanos, M., Lennon, K. M., Singh, G., Das, S., Van Keuren-Jensen, K., & Jovanovic-Talisman, T. (2023). Single Extracellular VEsicle Nanoscopy. Journal of Extracellular Vesicles, 12(7). https://doi.org/10.1002/jev2.12346
Vancouver
Saftics A, Abuelreich S, Romano E, Ghaeli I, Jiang N, Spanos M, et al. Single Extracellular VEsicle Nanoscopy. Journal of Extracellular Vesicles. 2023;12(7). doi:10.1002/jev2.12346
BibTeX
@article{Saftics2023,
author = {Saftics, Andras and Abuelreich, Sarah and Romano, Eugenia and Ghaeli, Ima and Jiang, Nan and Spanos, Michail and Lennon, Kathleen M and Singh, Gagandeep and Das, Saumya and Van Keuren-Jensen, Kendall and Jovanovic-Talisman, Tijana},
title = {Single Extracellular VEsicle Nanoscopy},
journal = {Journal of Extracellular Vesicles},
year = {2023},
volume = {12},
number = {7},
doi = {10.1002/jev2.12346}
}
EUVIMED